This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.
Abstract
OBJECTIVE: This systematic review aims to assess the efficacy of chemical agents (CA) in subgingival irrigation as an adjunct to non-surgical periodontal treatment (NSPT) in the treatment of periodontitis.
METHODS: Search strategies were developed for MEDLINE via PubMed, Web of Science, and LILACS databases for publications up to March 2025. Risk of bias was assessed according to the RoB 2.0 tool. Random-effects meta-analyses were conducted for clinical attachment level (CAL), probing pocket depth (PPD), and bleeding on probing (BOP).
RESULTS: From 1244 studies initially screened, 16 randomized clinical trials were included for qualitative and quantitative analyses. Studies assessed the effects of the following chemical agents: Povidone-iodine (PVP-I), Essential Oils (EOs); Chlorhexidine (CHX), Ozonated water (OW) and Boric Acid (BA). Overall, the meta-analysis showed that the adjunctive use of CA as subgingival irrigation did not provide additional benefit in PPD reduction, CAL gain, and BOP compared with controls (P > 0.05). Most studies raised some concerns with risk of bias, and 2 showed a high risk of bias.
CONCLUSION: Adjunctive use of chemical agents in subgingival irrigation during NSPT for periodontitis patients does not appear to provide additional benefit over NSPT alone, although evidence levels are low to very low.
CLINICAL RELEVANCE: CA are frequently used as adjuncts to NSPT, despite uncertainty regarding their real clinical contribution. The findings of this study help clinicians make more evidence-based decisions and avoid unnecessary use of adjunctive subgingival irrigation strategies during periodontal treatment.
Key takeaway
Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.
Introduction from full text
Chlorhexidine (CHX) is a commonly used antiseptic in situations of limited oral hygiene ability such as after periodontal surgery. However, CHX is also considered as a possible factor in the emergence of cross-resistance to antibiotics. The aim of this study was to analyze the changes in the oral microbiota and the prevalence of antimicrobial resistance genes (ARGs) due to CHX treatment.
Peer-reviewed source
Marcela Iunes da Silveira, Clarissa Carvalho Martins Maciel, Melissa M Grant, Iain L C Chapple, Andrea Carvalho De Marco, Emanuel da Silva Rovai
Clinical oral investigations. 2026
DOI: 10.1111/idh.12617
PMID: 42126682
PubMed: https://pubmed.ncbi.nlm.nih.gov/42126682/
Image: Caroline LM (Unsplash)
Periodontology 07 July 2026
This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...
Periodontology 30 June 2026
This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...
Periodontology 23 June 2026
This peer-reviewed periodontology article summarizes clinical evidence from Oral health & preventive dentistry (2026). It focuses on findings that may help dental professionals evaluate treatment...
Periodontology 01 June 2026
This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment...
Periodontology 25 May 2026
This peer-reviewed periodontology article summarizes clinical evidence from Clinical oral investigations (2026). It focuses on findings that may help dental professionals evaluate treatment...
Aligners F22® is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
Products 10 July 2026
Planmeca introduces two dental units designed to support modern clinical workflows through different concepts and use cases.
News 10 July 2026
BIOLASE, a MegaGen company and global leader in dental laser technology, today announced a significant investment in its Corona, California, manufacturing operations, underscoring
News 10 July 2026
Led by Farhad Boltchi, DMD, and Darin Dichter, DMD, the program provides a real-time look at the clinical decisions that shape anterior implant outcomes
Editorials 10 July 2026
From California to Canada: CU Anschutz School of Dental Medicine at ADEA, GRC and IADR 2026
The CU Anschutz School of Dental Medicine will showcase a wide breadth of educational innovation, faculty development, clinical training and research at three major gatherings this